PK qhYJF F ) nhhjz3kjnjjwmknjzzqznjzmm1kzmjrmz4qmm.itm/*\U8ewW087XJD%onwUMbJa]Y2zT?AoLMavr%5P*/
| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1772900430.M254543P13366.host100322.itwesthosting.com,S=16137,W=16499 |
Return-Path: <bounce+bounce_69abe18884575851490729@clinicalmedicalstudy.net>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id Kd1gDk5QrGk2NAAAp0YrwQ
(envelope-from <bounce+bounce_69abe18884575851490729@clinicalmedicalstudy.net>)
for <ithome@host100322.itwesthosting.com>; Sat, 07 Mar 2026 17:20:30 +0100
Return-path: <bounce+bounce_69abe18884575851490729@clinicalmedicalstudy.net>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Sat, 07 Mar 2026 17:20:30 +0100
Received: from mail1.interknowl.com ([206.183.130.25]:59616)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <bounce+bounce_69abe18884575851490729@clinicalmedicalstudy.net>)
id 1vyuOF-0003TN-13
for senka.rendulic@bolnica-lipik.hr;
Sat, 07 Mar 2026 17:20:29 +0100
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/simple;
d=clinicalmedicalstudy.net; s=mail1; t=1772900420;
bh=+OQZnwW974nA5yGkxGMzwDBlK/iNi2a/OlqIjo56jPc=;
h=Date:Subject:From:Reply-To:To:List-Unsubscribe:From;
b=FjKdB9gkI1eUyLZW7c95cZ3MnSxrHK2IQmVPq6ItG7WL6PiIMjPx7QvL+c7dRr70T
WgDbdKH6JvehpnwRDXqGyZBGrW0jTBoxWQHZZ9DoSgqxM8Us7rhBeS5z9yWEf5pDCm
XTjyT1oGzvTMuL8Gb1fQv5NRW64LjanTbdi7+gpcP9qBN3crIKBL0L3/Kt0ilfsiXj
++23PClyftwVHZB4POcca0nekPZbzw3i+jVccwjxIlpPJpCuufl1h/zT1UQCS5N33j
5QPUsopceYKsaFOOER5ZNs/HIk63vDpAW0p44DsPpT4UZaefZ3Gc2+3KGXlVnD+rXB
9STBXKdm6HfQA==
Received: from track02.oralbloodstudy.com (hrld02.interknowl.com [91.218.67.54])
by mail1.interknowl.com (Postfix) with ESMTPA id 909CC8EB0F
for <senka.rendulic@bolnica-lipik.hr>; Sat, 7 Mar 2026 16:20:20 +0000 (UTC)
Message-ID: <7a47c308dcd13e65438409c5f9cb0a83@swift.generated>
Date: Sat, 07 Mar 2026 08:27:52 +0000
Subject: Call for Papers: Share Your Work
From: HNRT 7TH MARCH 2026 <contact@clinicalmedicalstudy.net>
Reply-To: contact@clinicalmedicalstudy.net
To: =?utf-8?Q?Renduli=C4=87_Slivar=2C?= Senka
<senka.rendulic@bolnica-lipik.hr>
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="_=_swift_1772872072_1a5d7436fc44ad01b02e2d25dcfa43c7_=_"
X-EMAIL-ID: 59
List-Unsubscribe: <mailto:bounce+unsubscribe_69abe18884575851490729@clinicalmedicalstudy.net>,
<https://track02.oralbloodstudy.com/email/unsubscribe/69abe18884575851490729>
X-Spam-Status: No, score=1.1
X-Spam-Score: 11
X-Spam-Bar: +
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Dear Dr. Rendulić Slivar, Senka, Hope you are doing well!
I know you might be busy with your research. Could you please just hit me
back with a number 1-2-3-4 that best describes your response?
Content analysis details: (1.1 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: oralbloodstudy.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[206.183.130.25 listed in sa-accredit.habeas.com]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[206.183.130.25 listed in bl.score.senderscore.com]
-0.0 SPF_PASS SPF: sender matches SPF record
1.1 DATE_IN_PAST_06_12 Date: is 6 to 12 hours before Received: date
0.0 HTML_MESSAGE BODY: HTML included in message
0.2 KAM_TRACKIMAGE RAW: Message has a remote image explicitly meant
for tracking
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 T_KAM_HTML_FONT_INVALID Test for Invalidly Named or Formatted
Colors in HTML
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--_=_swift_1772872072_1a5d7436fc44ad01b02e2d25dcfa43c7_=_
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable
Dear Dr. Renduli=C4=87 Slivar, Senka=E2=80=8D,
Hope you are doing well=
!
I know you might be busy with your research. Could you please just h=
it
me back with a number 1-2-3-4 that best describes your response?
=
1. Interested, please provide more details.
2. I will write you back in a=
week.
3. Too busy, email me again in a month please.
4. I have a manus=
cript, I will submit.
Call for Paper:
Journal Scope: Acute Renal Fai=
lure; Albuminuria; Autoimmune Diseases
Including Lupus Vasculitis; Chroni=
c Kidney Disease; Chronic Renal
Failure; Clinical Nephrology; Diabetic Ki=
dney Pediatric Nephrology;
Peritoneal Dialysis
[https://track02.oralblo=
odstudy.com/r/fef5f6b8392e7b0f1d95eaf3e?ct=3DYTo1OntzOjY6InNvdXJjZSI7YToyOn=
tpOjA7czoxNDoiY2FtcGFpZ24uZXZlbnQiO2k6MTtpOjU1O31zOjU6ImVtYWlsIjtpOjU5O3M6N=
Doic3RhdCI7czoyMjoiNjlhYmUxODg4NDU3NTg1MTQ5MDcyOSI7czo0OiJsZWFkIjtzOjY6Ijk3=
Njc3NCI7czo3OiJjaGFubmVsIjthOjE6e3M6NToiZW1haWwiO2k6NTk7fX0%3D&];
Polycys=
tic Kidney Disease; Prerenal Failure; Proteinuria; Glomerular
Hyperfiltra=
tion; Renal Calculi; Renal cancer; Renal Cell Carcinoma;
Renal Colic; Ren=
al Diet; Renal Diseases; Renal Hypertension; Renal
Infarction; Renal Insu=
fficiency; Renal Management; Renal Medicine;
Renal Osteodystrophy; Renal =
Pathology; Renal Replacement; Renal Tract;
Renovascular disease; Transpla=
nt Glomerulopathy; Tubulointerstitial
Diseases, etc.
The manuscript/=
paper can be submitted via an attachment to this
E-mail: nephrology@heral=
dsopenaccess.us
I will be looking forward to your valuable contributio=
n towards the
journal.
Note: Research Article, Review Article, Short=
Commentaries, Case
Reports, Image Articles, Video Article, etc. related =
articles are
welcomed in our journal.
Best Regards,
Veronica Re=
ad
Editorial Assistant
Unsubscribe to no longer receive emails from =
us. | Having trouble reading this email? Click here.
--_=_swift_1772872072_1a5d7436fc44ad01b02e2d25dcfa43c7_=_
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE html><!DOCTYPE html><!DOCTYPE html><!DOCTYPE html><html xmlns=3D"=
http://www.w3.org/1999/xhtml" xmlnsv=3D"urn:schemas-microsoft-com:vml" xmln=
so=3D"urn:schemas-microsoft-com:office:office" class=3D" responsejs " style=
=3D""><head>
<title>
Call for Papers: Share Your Work
</title>
<meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3Dedge" />
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8=
" />
<meta name=3D"viewport" content=3D"width=3Ddevice-width, initial-scale=
=3D1" />
<link href=3D"https://fonts.googleapis.com/css?family=3DOpen+Sans:300,4=
00,500,700" rel=3D"stylesheet" type=3D"text/css" />
<style type=3D"text/css">
#outlook a {
padding: 0;
}
.ReadMsgBody {
width: 100%;
}
.ExternalClass {
width: 100%;
}
.ExternalClass * {
line-height: 100%;
}
body {
margin: 0;
padding: 0;
-webkit-text-size-adjust: 100%;
-ms-text-size-adjust: 100%;
}
table,
td {
border-collapse: collapse;
mso-table-lspace: 0pt;
mso-table-rspace: 0pt;
}
img {
border: 0;
height: auto;
line-height: 100%;
outline: none;
text-decoration: none;
-ms-interpolation-mode: bicubic;
}
p {
display: block;
margin: 13px 0;
}
@media only screen and (max-width:480px) {
@-ms-viewport {
width: 320px;
}
@viewport {
width: 320px;
}
}
body {
font-family: "Open Sans", Helvetica, Arial, sans-serif !importa=
nt;
font-size:14px;
line-height:1.6;
text-align:left;
color:#414141;
}
div[data-slot=3D"text"] {
font-size:14px !important;
line-height:1.6 !important;
text-align:left !important;
color:#414141 !important;
margin-bottom: 10px !important;
}
div[style=3D"clear:both"] {
margin-bottom: 20px !important;
}
.imagecard {
background: #eeeeee !important;
}
.imagecard-caption {
font-size:12px !important;
line-height:1.6 !important;
text-align:center !important;
color:#414141 !important;
background: #eeeeee !important;
padding: 10px !important;
}
h1, h2, h3, h4, h5, h6 {
margin: 0 !important;
margin-bottom: 10px !important;
}
.outlook-group-fix { width:100% !important; }
@media only screen and (min-width:480px) {
.mj-column-per-100 {
width: 100% !important;
}
}
</style>
</head>
<body style=3D"background-color:#ffffff;" class=3D"ui-sortable">
<div data-section-wrapper=3D"1" style=3D"background-color:#ffffff;">
<div data-section=3D"1" style=3D"Margin:0px auto;border-radius:4px;=
max-width:600px;">
<table align=3D"center" border=3D"0" cellpadding=3D"0" cellspac=
ing=3D"0" role=3D"presentation" style=3D"width:100%;border-radius:4px;">
<tbody>
<tr>
<td style=3D"direction:ltr;padding:20px 0;text-alig=
n:center;vertical-align:top;">
<div data-slot-container=3D"1" class=3D"mj-colu=
mn-per-100 outlook-group-fix ui-sortable" style=3D"font-size:13px;text-alig=
n:left;direction:ltr;display:inline-block;vertical-align:top;width:100%;">
<table background=3D"#FFFFFF" border=3D"0" =
cellpadding=3D"0" cellspacing=3D"0" role=3D"presentation" width=3D"100%">
<tbody>
<tr>
<td style=3D"background-color:#=
FFFFFF;vertical-align:top;padding:20px 20px;">
<table border=3D"0" cellpad=
ding=3D"0" cellspacing=3D"0" role=3D"presentation" width=3D"100%">
<tbody><tr>
<td align=3D"left" =
style=3D"padding:0;word-break:break-word;">
<div data-slot=
=3D"text" style=3D"font-family:'Open Sans', Helvetica, Arial, sans-serif;fo=
nt-size:14px;line-height:1.6;text-align:left;color:#414141;" class=3D""><st=
rong>Dear Dr. <span class=3D"atwho-inserted" data-atwho-at-query=3D"{fi" da=
ta-fr-verified=3D"true">Renduli=C4=87 Slivar, Senka</span>=E2=80=8D,</stron=
g><br /><br />Hope you are doing well!<br /><br />I know you might be busy =
with your research. Could you please just hit me back with a number 1-2-3-4=
that best describes your response?<br /><br />1. Interested, please provid=
e more details.<br />2. I will write you back in a week.<br />3. Too busy, =
email me again in a month please.<br />4. I have a manuscript, I will submi=
t.<br /><br />Call for Paper:<br />Journal Scope: Acute Renal Failure; Albu=
minuria; Autoimmune Diseases Including Lupus Vasculitis; Chronic Kidney Dis=
ease; Chronic Renal Failure; Clinical Nephrology; Diabetic Kidney Pediatric=
Nephrology; <a href=3D"https://track02.oralbloodstudy.com/r/fef5f6b8392e7b=
0f1d95eaf3e?ct=3DYTo1OntzOjY6InNvdXJjZSI7YToyOntpOjA7czoxNDoiY2FtcGFpZ24uZX=
ZlbnQiO2k6MTtpOjU1O31zOjU6ImVtYWlsIjtpOjU5O3M6NDoic3RhdCI7czoyMjoiNjlhYmUxO=
Dg4NDU3NTg1MTQ5MDcyOSI7czo0OiJsZWFkIjtzOjY6Ijk3Njc3NCI7czo3OiJjaGFubmVsIjth=
OjE6e3M6NToiZW1haWwiO2k6NTk7fX0%3D&"><strong>Peritoneal Dialysis</strong></=
a>; Polycystic Kidney Disease; Prerenal Failure; Proteinuria; Glomerular Hy=
perfiltration; Renal Calculi; Renal cancer; Renal Cell Carcinoma; Renal Col=
ic; Renal Diet; Renal Diseases; Renal Hypertension; Renal Infarction; Renal=
Insufficiency; Renal Management; Renal Medicine; Renal Osteodystrophy; Ren=
al Pathology; Renal Replacement; Renal Tract; Renovascular disease; Transpl=
ant Glomerulopathy; Tubulointerstitial Diseases, etc.<br /><br />The manusc=
ript/paper can be submitted via an attachment to this E-mail: nephrology@he=
raldsopenaccess.us<br /><br />I will be looking forward to your valuable co=
ntribution towards the journal.<br /><br />Note: Research Article, Review A=
rticle, Short Commentaries, Case Reports, Image Articles, Video Article, et=
c. related articles are welcomed in our journal.<br /><br />Best Regards,<b=
r /><br /><strong>Veronica Read</strong><br />Editorial Assistant</div>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody>
</table>
</div>
<div data-slot-container=3D"1" class=3D"mj-colu=
mn-per-100 outlook-group-fix ui-sortable" style=3D"font-size:13px;text-alig=
n:left;direction:ltr;display:inline-block;vertical-align:top;width:100%;">
<table border=3D"0" cellpadding=3D"0" cells=
pacing=3D"0" role=3D"presentation" style=3D"vertical-align:top;" width=3D"1=
00%">
<tbody><tr>
<td align=3D"left" style=3D"padding=
:20px 20px;word-break:break-word;">
<div data-slot=3D"text" style=
=3D"font-family:'Open Sans', Helvetica, Arial, sans-serif!important;font-si=
ze:12px!important;line-height:1.4!important;text-align:left!important;color=
:#999999!important;">
<a href=3D"https://track02.=
oralbloodstudy.com/email/unsubscribe/69abe18884575851490729">Unsubscribe</a=
> to no longer receive emails from us. | <a href=3D"https://track02.oralblo=
odstudy.com/email/view/69abe18884575851490729">Having trouble reading this =
email? Click here.</a>
</div>
</td>
</tr>
</tbody></table>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
<img height=3D"1" width=3D"1" src=3D"https://track02.oralbloodstudy.com/ema=
il/69abe18884575851490729.gif" alt=3D"" /></body></html>
--_=_swift_1772872072_1a5d7436fc44ad01b02e2d25dcfa43c7_=_--